XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020   148,615,351    
Beginning balance at Dec. 31, 2020 $ 130,266 $ 1,476 $ 755,874 $ (627,084)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock from option exercises (in shares)   6,021    
Issuance of common stock from option exercises 19   19  
Stock-based compensation 8,494   8,494  
Issuance of common stock from releases of restricted stock units (in shares)   1,209,870    
Issuance of common stock from releases of restricted stock units 0 $ 12 (12)  
Tax withholding paid on behalf of employees for stock-based awards (1,473)   (1,473)  
Issuance of common stock upon public offering, net (in shares)   11,856,500    
Issuance of common stock upon public offering (net of offering cost of $3,991) 53,513 $ 119 53,394  
Issuance of common stock from warrant exercises (in shares)   42,621    
Issuance of common stock from warrant exercises 2   2  
Reclassification of warrant liability to additional paid-in capital upon warrant exercises 327   327  
Net loss (26,743)     (26,743)
Ending balance (in shares) at Mar. 31, 2021   161,730,363    
Ending balance at Mar. 31, 2021 164,405 $ 1,607 816,625 (653,827)
Beginning balance (in shares) at Dec. 31, 2020   148,615,351    
Beginning balance at Dec. 31, 2020 130,266 $ 1,476 755,874 (627,084)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (57,719)      
Ending balance (in shares) at Jun. 30, 2021   163,590,744    
Ending balance at Jun. 30, 2021 139,051 $ 1,624 822,230 (684,803)
Beginning balance (in shares) at Mar. 31, 2021   161,730,363    
Beginning balance at Mar. 31, 2021 164,405 $ 1,607 816,625 (653,827)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock from option exercises (in shares)   37,630    
Issuance of common stock from option exercises 165   165  
Stock-based compensation 6,455   6,455  
Issuance of common stock from releases of restricted stock units (in shares)   1,738,516    
Issuance of common stock from releases of restricted stock units 0 $ 17 (17)  
Tax withholding paid on behalf of employees for stock-based awards (1,286)   (1,286)  
Issuance of common stock from warrant exercises (in shares)   2,431    
Reclassification of warrant liability to additional paid-in capital upon warrant exercises 24   24  
Issuance of common stock from employee stock purchase plan (in shares)   81,804    
Issuance of common stock from employee stock purchase plan 264   264  
Net loss (30,976)     (30,976)
Ending balance (in shares) at Jun. 30, 2021   163,590,744    
Ending balance at Jun. 30, 2021 139,051 $ 1,624 822,230 (684,803)
Beginning balance (in shares) at Dec. 31, 2021   179,206,456    
Beginning balance at Dec. 31, 2021 169,795 $ 1,782 905,145 (737,132)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock from option exercises (in shares)   19,292    
Issuance of common stock from option exercises 56   56  
Stock-based compensation 5,032   5,032  
Issuance of common stock from releases of restricted stock units (in shares)   1,216,278    
Issuance of common stock from releases of restricted stock units 0 $ 12 (12)  
Tax withholding paid on behalf of employees for stock-based awards (1,604)   (1,604)  
Net loss (25,774)     (25,774)
Ending balance (in shares) at Mar. 31, 2022   180,442,026    
Ending balance at Mar. 31, 2022 147,505 $ 1,794 908,617 (762,906)
Beginning balance (in shares) at Dec. 31, 2021   179,206,456    
Beginning balance at Dec. 31, 2021 $ 169,795 $ 1,782 905,145 (737,132)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock from option exercises (in shares) 24,208      
Net loss $ (53,407)      
Ending balance (in shares) at Jun. 30, 2022   180,997,543    
Ending balance at Jun. 30, 2022 124,818 $ 1,800 913,557 (790,539)
Beginning balance (in shares) at Mar. 31, 2022   180,442,026    
Beginning balance at Mar. 31, 2022 147,505 $ 1,794 908,617 (762,906)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock from option exercises (in shares)   4,916    
Issuance of common stock from option exercises 11   11  
Stock-based compensation 5,101   5,101  
Issuance of common stock from releases of restricted stock units (in shares)   406,895    
Issuance of common stock from releases of restricted stock units 0 $ 4 (4)  
Tax withholding paid on behalf of employees for stock-based awards (490)   (490)  
Issuance of common stock from employee stock purchase plan (in shares)   143,706    
Issuance of common stock from employee stock purchase plan 324 $ 2 322  
Net loss (27,633)     (27,633)
Ending balance (in shares) at Jun. 30, 2022   180,997,543    
Ending balance at Jun. 30, 2022 $ 124,818 $ 1,800 $ 913,557 $ (790,539)